FGFR4 and hepatocellular carcinoma: Two different FGFR4 gene polymorphisms have been associated with increased levels of a-fetoprotein in HCC patients (Ho et al., 2009; Yang et al., 2012b; Sheu et al., 2015; Xie et al., 2015).